Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2016 15:02 ET | Source: VBI Vaccines, Inc.

Additional Details Relating to the SciVac Therapeutics and VBI Vaccines Merger Transaction

SciVac Therapeutics changed its name to VBI VaccinesOn May 6, 2016, each share of VBI Vaccines common stock was converted into the right to receive 0.520208 common shares of post-merger VBI VaccinesOn...
May 09, 2016 08:30 ET | Source: VBI Vaccines, Inc.

SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction

SciVac Therapeutics changes its name to VBI VaccinesCombined company to begin trading on The NASDAQ Capital Market under the symbol “VBIV”Combined company is a biotechnology company with a licensed...
April 28, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the Bloom Burton Healthcare Investor Conference

CAMBRIDGE, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the Bloom Burton Healthcare Investor Conference on Monday, May 2nd at 1:30 PM...
April 14, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines and SciVac Therapeutics Announce Effectiveness of Registration Statement on Form F-4

CAMBRIDGE, Mass., April 14, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) and SciVac Therapeutics Inc. (TSX:VAC) (OTCQX:SVACF) (“SciVac”) announced today that the registration...
March 29, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the World Vaccine Congress Washington

CAMBRIDGE, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the World Vaccine Congress Washington on Wednesday, March 30th, 2016 at 12:10...
March 07, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

CAMBRIDGE, Mass., March 07, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) today will present new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer...
March 03, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the ROTH Conference

CAMBRIDGE, Mass., March 03, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the 28th Annual ROTH Conference on Tuesday, March 15th, 2016 at 5:30 PM PT...
February 09, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability

CAMBRIDGE, Mass., Feb. 09, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s...
February 04, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Partners with the Canadian CMV Foundation to Raise Congenital Cytomegalovirus Awareness

CAMBRIDGE, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is proud to announce its continued sponsorship support of Le Classique, the Canadian CMV Foundation’s...
January 26, 2016 08:30 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the BIO CEO & Investor Conference

CAMBRIDGE, Mass., Jan. 26, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the BIO CEO & Investor Conference on Tuesday, February 9th, 2016 at 1:00 PM...